semaglutide immune system Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review | Pharmaceutical Research Semaglutide: What we know about

A genetic-informed approach means your clinician can anticipate your likely response pattern and adjust dosing strategy accordingly

Footnotes [1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic

PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) maps these 14 pathways across 49 peptides to help you understand your personalized response to semaglutide and predict how well cravings will decrease

Indications and Contraindications: Indications include individuals with a body mass index (BMI) of 30 or higher or those with a BMI of at least 27 with one or more weight-related comorbidities, such as hypertension or type 2 diabetes